Screener
CONMED CNMD United States — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended / June 30, 2026 / Orthopedic Surgery | Three Months Ended / June 30, 2026 / General Surgery | Three Months Ended / June 30, 2026 / Total | Three Months Ended / June 30, 2025 / Orthopedic Surgery | Three Months Ended / June 30, 2025 / General Surgery | Three Months Ended / June 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Primary Geographic Markets | ||||||
| United States | $51,653 | $123,732 | $175,385 | $51,687 | $138,925 | $190,612 |
| Europe, Middle East & Africa | 40,305 | 35,842 | 76,147 | 35,588 | 32,189 | 67,777 |
| Asia Pacific | 36,561 | 20,596 | 57,157 | 31,736 | 20,345 | 52,081 |
| Americas (excluding the United States) | 23,796 | 11,003 | 34,799 | 21,723 | 10,152 | 31,875 |
| Total sales from contracts with customers | $152,315 | $191,173 | $343,488 | $140,734 | $201,611 | $342,345 |
| Timing of Revenue Recognition | ||||||
| Goods transferred at a point in time | $139,852 | $188,205 | $328,057 | $129,382 | $199,065 | $328,447 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's united states — net sales?
- CONMED (CNMD) reported united states — net sales of $175.39M in Q2 2026.
- How has CONMED's united states — net sales changed year-over-year?
- CONMED's united states — net sales decreased by 8.0% year-over-year, from $190.61M to $175.39M.
- What is the long-term trend for CONMED's united states — net sales?
- Over 4 years (2021 to 2025), CONMED's united states — net sales has grown at a 8.8% compound annual growth rate (CAGR), from $552.53M to $774.59M.
- What does united states — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and surgical equipment within the United States geographic market. It serves as a primary indicator of the company's domestic market penetration and the demand for its orthopedic and general surgery product portfolios. Growth in this figure reflects successful commercial execution and the ability to capture market share within the U.S. healthcare system.
Ask your AI about CONMED's united states — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude